Loading clinical trials...
Loading clinical trials...
A Multicenter Phase II Study Evaluating BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for First and Second Chemosensitive Relapses in Patients With Follicular Lymphoma
Conditions
Interventions
BeEAM
Locations
13
France
CHU de Dijon - Hôpital Le Bocage
Dijon, Côte d'Or, France
Centre Henri Becquerel
Rouen, Haute Normandie, France
CHRU de Lille Hôpital Claude Huriez
Lille, Hauts-de-France, France
CHRU de Montpellier, Hôpital Saint-Eloi
Montpellier, Hérault, France
CHU de Rennes - Hôpital Pontchaillou
Rennes, Ille Et Vilaine, France
CHU Grenoble - Hôpital Michallon
Grenoble, Isère, France
Start Date
July 9, 2014
Primary Completion Date
July 12, 2018
Completion Date
July 12, 2018
Last Updated
January 8, 2019
NCT06337318
NCT05006716
NCT06026319
NCT07128641
NCT06510361
NCT01804686
Lead Sponsor
Centre Leon Berard
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions